person · Reporting owner

Pomeroy JL

Disclosed activity across 1 company

Tapewire entity: 164661
SEC CIK: 0001747731

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
IMAX CORPIMAX · Entity 4276	Chief Marketing Officer	July 27, 2018	July 31, 2018

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

IMAX CORP

Report date July 27, 2018 · Filed July 31, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
stock options (to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.75 · Expires 2025-07-27	Direct	26,215	Reported balance After 2018-07-27 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2018-07-27 · Grant · Acquired 26,215 · Balance 26,215 F1: The stock options become exercisable in 4 installments: 5,243 on July 27, 2019; 6,553 on each of July 27, 2020 and July 27, 2021; and 7,866 on July 27, 2022. F2: Ms Pomeroy's aggregate outstanding option, restricted share unit and common share balances following these transactions will be 38,438; 34,944 and 0 respectively.
restricted share unitsSEC Table II · derivative / convertible security · Expires 2022-08-26	Direct	23,793	Reported balance After 2018-07-27 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2018-07-27 · Grant · Acquired 23,793 · Balance 23,793 F3: Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. F4: Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. F5: The restricted share units vest and will be converted to common shares in 4 installments: 4,758 on July 27, 2019; 5,948 on each of July 27, 2020 and July 27, 2021; and 7,139 on July 27, 2022. F2: Ms Pomeroy's aggregate outstanding option, restricted share unit and common share balances following these transactions will be 38,438; 34,944 and 0 respectively.
common sharesSEC Table I · non-derivative	Direct	0	Reported balance Holding disclosure · report date 2018-07-27 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 0

Filing footnotes · ownership attribution and instrument terms

F1: The stock options become exercisable in 4 installments: 5,243 on July 27, 2019; 6,553 on each of July 27, 2020 and July 27, 2021; and 7,866 on July 27, 2022.

F2: Ms Pomeroy's aggregate outstanding option, restricted share unit and common share balances following these transactions will be 38,438; 34,944 and 0 respectively.

F3: Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation.

F4: Each restricted share unit is the economic equivalent of one common share of IMAX Corporation.

F5: The restricted share units vest and will be converted to common shares in 4 installments: 4,758 on July 27, 2019; 5,948 on each of July 27, 2020 and July 27, 2021; and 7,139 on July 27, 2022.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
July 27, 2018 Filed Jul 31, 2018 21:01 UTC	IMAX CORP IMAX · Entity 4276	Grantrestricted share units · Derivative	23,793	Not disclosed	Not disclosed	Disclosure SEC source: 0001214659-18-005076 · marketforms-42574.xml · derivative · entry 3 Pomeroy JL · CIK 0001747731 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,793 Underlying: common shares · 23,793 shares Expires 2022-08-26 F3 · security: Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. F4 · derivative.exercise_price: Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. F4 · price: Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. F5 · derivative.exercise_date: The restricted share units vest and will be converted to common shares in 4 installments: 4,758 on July 27, 2019; 5,948 on each of July 27, 2020 and July 27, 2021; and 7,139 on July 27, 2022. F2 · balance_after: Ms Pomeroy's aggregate outstanding option, restricted share unit and common share balances following these transactions will be 38,438; 34,944 and 0 respectively. Read SEC document
July 27, 2018 Filed Jul 31, 2018 21:01 UTC	IMAX CORP IMAX · Entity 4276	Grantstock options (to buy) · Derivative	26,215	$21.75 Strike: $21.75	$570,176.25	Disclosure SEC source: 0001214659-18-005076 · marketforms-42574.xml · derivative · entry 2 Pomeroy JL · CIK 0001747731 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,215 Underlying: common shares · 26,215 shares Expires 2025-07-27 F1 · derivative.exercise_date: The stock options become exercisable in 4 installments: 5,243 on July 27, 2019; 6,553 on each of July 27, 2020 and July 27, 2021; and 7,866 on July 27, 2022. F2 · balance_after: Ms Pomeroy's aggregate outstanding option, restricted share unit and common share balances following these transactions will be 38,438; 34,944 and 0 respectively. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.